In collaboration with Eurofins Viracor Biopharma, Eurofins Central Laboratory in Shanghai, China, has expanded its respiratory syncytial virus (RSV) detection capacity since 2021 to support the rapid needs of clients for clinical research on respiratory syncytial virus (RSV). The Eurofins Central Laboratory sites in the Netherlands and Singapore have completed the installation of this … [Read more...] about Eurofins Central Laboratory China expands its offering to include RSV (respiratory syncytial virus) testing
Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing and clinical diagnostics testing, announces the completion of the acquisition of a majority stake in Repertoire Genesis Inc. (“RG”). RG owns a unique and proprietary analytical platform, TCR/BCR (T Cell Receptor/B Cell Receptor) repertoire profiling, that enables scientists to determine the specific … [Read more...] about Eurofins enhances its clinical and BioPharma service offering in Japan with immune repertoire analysis technology through the acquisition of Repertoire Genesis Inc.
Eurofins Technologies continues to innovate and develop a wide range of diagnostic solutions for COVID-19, particularly in response to the threat of emerging mutations. In the past days, researchers have identified a new SARS-CoV-2 variant with a concerningly high number of mutations in the spike protein. The variant was first identified in Botswana in November 2021, is spreading rapidly across … [Read more...] about Eurofins Technologies announces the launch of RT-PCR kits for the rapid detection of the fast spreading SARS-CoV-2 variant B.1.1.529
Emmes, a leading global full-service clinical research organization (CRO), together with its rare disease CRO Orphan Reach, today announced it has signed a new five-year service agreement to extend its current relationship with Eurofins Central Laboratory. Emmes is dedicated to helping private sector, government, non-profit and academic partners achieve their biopharmaceutical development and … [Read more...] about CRO Emmes signs new five-year service agreement with Eurofins Central Laboratory
Provides significantly higher positive predictive value (PPV) and negative predictive value (NPV) than any other kidney rejection assays (or tests) on the market. Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide, is pleased to introduce OmniGraf™, which combines the TruGraf® blood gene expression test … [Read more...] about Transplant Genomics Launches OmniGraf™, the Only Combination Biomarker Panel That Provides the Earliest Indication of Rejection in Kidney Transplant Recipients
Eurofins, through its empowerDX subsidiary, and Rite Aid announce the launch of an over-the-counter, FDA-authorised, at-home COVID-19 PCR Test Kit. The co-branded kits, available at all Rite Aid stores across 17 states in the USA, will offer customers a convenient way to test for the virus from their home and will detect the virus in symptomatic and asymptomatic patients. The at-home … [Read more...] about Eurofins and Rite Aid launch an over-the-counter, FDA-authorized, at-home COVID-19 PCR test in all Rite Aid locations in the U.S.
Eurofins Transplant Genomics, Inc. (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide, is excited to announce the first national in-network contract for TruGraf, its proprietary gene expression test for subclinical acute rejection. Humana, a leading health care company that offers a wide range of insurance products and health and … [Read more...] about TruGraf contracted with Humana for in-network coverage of Medicare kidney transplant patients
Easy, reliable, high-quality, and cost-effective testing for SARS-CoV-2 (COVID-19), in compliance with local regulatory requirements, is crucial to enabling millions of passengers to complete their journeys in comfort and safety. Eurofins has rapidly developed a broad network of around 500 testing centers across Europe and intends to have established around 1,000 testing centers by early … [Read more...] about Eurofins opens Europe-wide COVID-19 testing center network to facilitate summer travel
Eurofins Scientific (“Eurofins”), a global scientific leader in bioanalytical testing, announces that its subsidiary Eurofins Clinical Testing US Holdings, Inc. has entered into an agreement to acquire DNA Diagnostics Center (“DDC”), a leader in consumer genetic testing. DDC anticipates delivering revenues of over US$55m in 2021. DDC is one of the most highly accredited genetic-testing … [Read more...] about Eurofins to acquire DNA Diagnostics Center to grow genetic testing capabilities and significantly expand further into consumer testing market
Eurofins Technologies announces the launch of its GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 Variants of Concern including B.1.617, B.1.427/B.1.429, B.1.351 or P.1. The assay facilitates the identification of the relevant mutations E484Q, E484K and L452R in one reaction combined with the simultaneous discrimination from the S gene E484 … [Read more...] about Eurofins launches a new multiplex PCR assay for rapid detection of the B.1.617 SARS-CoV-2 variant